Effects of Acute Ingestion of Dark Chocolate on Endothelial Function in Hypertensive Patients
- Conditions
- Hypertension
- Interventions
- Dietary Supplement: Dark chocolate
- Registration Number
- NCT01314924
- Lead Sponsor
- Hospital Universitario Pedro Ernesto
- Brief Summary
We aimed to identify clinical and vascular parameters of treated hypertensive patients who present beneficial effects of dark chocolate for one-week period on vascular function.
- Detailed Description
Recent findings indicate an inverse relationship between cardiovascular disease and consumption of flavonoids. We aimed to identify clinical and vascular parameters of treated hypertensive patients who present beneficial effects of dark chocolate for one-week period on vascular function. Twenty-one hypertensive patients in drug therapy, both genders, aged 40-65 years, were included in a prospective study with measurement of blood pressure, brachial flow-mediated dilatation (FMD), peripheral arterial tonometry (EndoPAT) and central hemodynamic parameters by SphygmoCor. After seven days of eating dark chocolate (70% cocoa) 75g/day, the clinical and vascular evaluation were repeated. Patients were divided into two groups according to the response in FMD: responders (increase in FMD, n=12) and non-responders (no improvement in FMD, n=9).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
- Previous diagnosis of hypertension
- Use of one or two antihypertensive drugs
- Systolic blood pressure between 130 and 160 mmHg
- Diastolic blood pressure between 85 and 100 mmHg
- Secondary hypertension
- Diabetes mellitus
- Body mass index > 35kg/m2
- Chronic kidney disease
- Known coronary artery disease
- Previous stroke
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Responders Dark chocolate Patients who present an increase in flow-mediated dilation of brachial artery. Non responders Dark chocolate Patients who do not present an increase in flow-mediated dilation of brachial artery.
- Primary Outcome Measures
Name Time Method Endothelial function One week Endothelial function evaluated by peripheral arterial tonometry and by flow-mediated dilation of brachial artery
- Secondary Outcome Measures
Name Time Method Blood pressure One week Systolic and diastolic blood pressure levels evaluated by an automatic device
Central hemodynamic parameters One week Aortic systolic blood pressure and pulse pressure evaluated by SphygmoCor. Vascular stiffness parameters such as augmentation pressure and augmentation index will also be evaluated.
Trial Locations
- Locations (1)
Hospital Universitario Pedro Ernesto
🇧🇷Rio de Janeiro, RJ, Brazil